News Quantified

EBS – emergent biosolutions inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Emergent (EBS) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]

Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility

Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026

Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

35.2%

BEAT

32.5%

BEAT

34.2%

BEAT

Form DEFA14A Emergent BioSolutions

Form DEFA14A Emergent BioSolutions

Form 8-K Emergent BioSolutions For: Apr 16

Form DEFA14A Emergent BioSolutions

Form DEFA14A Emergent BioSolutions

Top News Gainers

8/30 Emergent BioSolutions (EBS) Investor Presentation - Slideshow [Seeking Alpha] 14.7%

9/4 Form 8-K Emergent BioSolutions For: Aug 30 10.7%

3/10 Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday [The Motley Fool] 10.2%

3/4 Emergent BioSolutions Selects Axiom Fusion eClinical Suite as Its Global eClinical Suite 9.2%

5/1 Form 8-K/A Emergent BioSolutions For: Apr 30 8.9%

4/23 Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19 8.5%

6/3 Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness 8.2%

4/27 Emergent Biosolutions Inc (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $71.00 price target on the stock. 7.2%

2/27 Form 4 Emergent BioSolutions For: Feb 25 Filed by: Strei Katherine 6.1%

3/11 Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus Disease 5.3%

Top News Decliners

3/13 Why These Drug Stocks Soared Today [The Motley Fool] -15.6%

3/6 Form 3/A Emergent BioSolutions For: Mar 05 Filed by: Kirk Sean -10.5%

11/7 Emergent Biosolutions Inc (NYSE: EBS) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $67.00 price target on the stock. -10.0%

3/10 Here's Why Emergent BioSolutions Jumped Higher on Tuesday [The Motley Fool] -9.3%

3/31 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ -6.1%

4/20 Form 4 Emergent BioSolutions For: Apr 16 Filed by: El-Hibri Fuad -5.7%

10/21 Emergent BioSolutions to Host 2019 Analyst & Investor Day -5.2%

9/10 Form 4 Emergent BioSolutions For: Sep 09 Filed by: Zoon Kathryn C -4.9%

3/2 Form 4 Emergent BioSolutions For: Feb 27 Filed by: Bailey Sue -4.6%

10/7 Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September [The Motley Fool] -4.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day